Nichols has been studying how the amyloid-β protein interacts with a group of three proteins known as NLRP3 inflammasome to cause inflammation inside immune cells in the brain.
LATEST IN Mayo Clinic
Chemistry Professor Michael Nichols discusses his research on Alzheimer’s disease as part of NextGen Precision Health’s Discovery Series
Nichols has been studying how the amyloid-β protein interacts with a group of three proteins known as NLRP3 inflammasome to cause inflammation inside immune cells in the brain.
Chemistry Professor Michael Nichols discusses his research on Alzheimer’s disease as part of NextGen Precision Health’s Discovery Series
Nichols has been studying how the amyloid-β protein interacts with a group of three proteins known as NLRP3 inflammasome to cause inflammation inside immune cells in the brain.
Whitney and Anna Harris Conservation Forum takes attendees on tour of seldom-seen cave ecosystems
About 150 people attended the 29th annual forum, which featured presentations from biologists Vona Kuczynska, Matthew Niemiller and Jut Wynne.
UMSL community gathers to celebrate research excellence at annual Research and Innovation Reception
Faculty members Mary Edwin, Emily Brown, Anita Manion, Rachel Winograd, Vivek Singh and Michael Nichols were honored at Friday’s event in the Millennium Student Center.
UMSL community gathers to celebrate research excellence at annual Research and Innovation Reception
Faculty members Mary Edwin, Emily Brown, Anita Manion, Rachel Winograd, Vivek Singh and Michael Nichols were honored at Friday’s event in the Millennium Student Center.
UMSL community gathers to celebrate research excellence at annual Research and Innovation Reception
Faculty members Mary Edwin, Emily Brown, Anita Manion, Rachel Winograd, Vivek Singh and Michael Nichols were honored at Friday’s event in the Millennium Student Center.
Michael Nichols conducting NIH-funded research into chemical mechanisms that lead to brain inflammation in Alzheimer’s patients
Nichols received a $459,279 grant from the National Institute of General Medical Sciences to study the mechanisms of NLRP3 inflammasome activation.
Michael Nichols conducting NIH-funded research into chemical mechanisms that lead to brain inflammation in Alzheimer’s patients
Nichols received a $459,279 grant from the National Institute of General Medical Sciences to study the mechanisms of NLRP3 inflammasome activation.
Michael Nichols conducting NIH-funded research into chemical mechanisms that lead to brain inflammation in Alzheimer’s patients
Nichols received a $459,279 grant from the National Institute of General Medical Sciences to study the mechanisms of NLRP3 inflammasome activation.
MORE IN Mayo Clinic
LATEST NEWS
- Whitney and Anna Harris Conservation Forum takes attendees on tour of seldom-seen cave ecosystems
- Chancellor Kristin Sobolik honored by Girls Inc. of St. Louis
- Veterans Day ceremony highlights UMSL’s commitment to supporting student veterans
- Eye on UMSL: Swag prep
- Associate Professor Lindsay Athamanah receives Emerson’s Excellence in Teaching Award
- 12th annual International Business Case Competition draws talent from across the country
- UMSL Tritons weekly rewind
- UMSL esports program more than fun and games for players
- Bridge Program graduates and UMSL freshmen Kauthar Hammad, Taylor Moore and Marlo Shivers honored as Suggs Scholars
- UMSL, FOCUS St. Louis working together to grow leaders today and in the future
